KaloBios Pharmaceuticals, Inc. Appoints Martin Shkreli CEO and Announces New Financing
November 20, 2015 at 05:39 AM EST
KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that an investor group led by Martin Shkreli, the Founder and Chief ...
